“Novel Acrylamide Inhibitor HC-258 Binds to TEAD Protein and Inhibits Breast Cancer Cell Migration”

https://pubmed.ncbi.nlm.nih.gov/38116405

Researchers have developed a novel covalent acrylamide inhibitor called HC-258, which binds to TEAD protein and reduces the expression of certain genes and inhibits migration of breast cancer cells.